Many oncology practices treat patients with benign and malignant hematologic diagnoses. As a result, oncology nurses often are required to care for these patients. One common procedure nurses perform is therapeutic phlebotomy, where about 500 ml of blood is removed through a large-bore needle over 15-30 minutes. The procedure is ordered as a treatment for hereditary hemochromatosis, polycythemia vera, and secondary polycythemia. Before initiating the procedure, nurses must be aware of a patient's diagnosis, baseline hemoglobin, hematocrit, ferritin, and therapeutic end points. Reviewing these diagnoses will help nurses understand why phlebotomy is an important part of treatment.
Adams, P. C., & Barton, J. C. (2010). How I treat hemochromatosis. <i>Blood, 116</i>, 317-325.
Finazzi, G., & Barbui, T. (2007). How I treat patients with polycythemia vera. <i>Blood, 109</i>, 5104-5110.
Hocking, W. G. (2002). Primary and secondary erythrocytosis. In J. J. Mazza (Ed.), <i>Manual of clinical hematology</i> (3rd ed., pp. 73-89). Philadelphia, PA: Lippincott Williams and Wilkins.
Lashley, F. R. (1998). <i>Clinical genetics in nursing practice</i> (2nd ed.). New York, NY: Springer.
McLaren, G. D. (2002). Hereditary hemochromastosis and other iron-overloaded disorders. In J. J. Mazza (Ed.), <i>Manual of clinical hematology</i> (3rd ed., pp. 118-137). Philadelphia, PA: Lippincott Williams and Wilkins.
Schrier, S. L., & Bacon, B. R. (2009). <i>Treatment of hereditary hemochromatosis.</i> Retrieved from <a target="_blank" href='http://www.utdol.com/online/content/topic.do?topicKey=red_cell/30819.pdf...
Tefferi, A. (2007). <i>Diagnostic approach to the patient with polycythemia.</i> Retrieved from <a target="_blank" href='http://www.utdol.com/online/content.topic.do?topic.Key=red_cell/12173.pd...
Tefferi, A. (2010). <i>Prognosis and treatment of polycythemia vera.</i> Retrieved from <a target="_blank" href='http://www.utdol.com/online/content.topic.do?topic.Key=leukemia/7076.pdf...
Vannucchi, A. M., Guglielmelli, P., & Tefferi, A. (2009). Advances in understanding and management of myeloproliferative neoplasms. <i>CA: A Cancer Journal for Clinicians, 59</i>, 171-191.